So They Say

Verbatim excerpts from the media on the conduct of science. Another Japanese Target The Japanese readily concede that they trail the West in biotechnology, the use of engineering techniques to study living organisms. But cross biotech with electronics, and the story is different. In this new, hybrid field, called bioelectronics, Japan boasts of a lead in moving from lab to market. "Japan is ahead, without a doubt," says Isao Karube, biotechnology professor at Tokyo Institute of Technology. A big

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

In this new, hybrid field, called bioelectronics, Japan boasts of a lead in moving from lab to market. "Japan is ahead, without a doubt," says Isao Karube, biotechnology professor at Tokyo Institute of Technology.

A big part of that lead is a tiny device created by fusing organic matter to electrodes. Called a biosensor, the device converts natural chemical reactions into electric current to measure blood-sugar levels, monitor the brewing of beer, sniff out pollution, pick the freshest fish in the market or become a robot's "nose."

"It's the same old story," says Christopher Lowe, director of the biotechnology center at Britain's Cambridge University. Biosensors "have been targeted in the usual, thorough way." The West still leads in basic biosensor studies…. But the Japanese "will walk away with the commercial applications in this area," he says.

Accepting foreign students is an American tradition that we must continue, in part because ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies